{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T16:40:04Z","timestamp":1750092004961,"version":"3.41.0"},"posted":{"date-parts":[[2025,1,21]]},"group-title":"In Review","reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,12,31]]},"abstract":"<title>Abstract<\/title>\n        <p>Background:\n Molecular surveillance of drug-resistant <italic>Plasmodium falciparum<\/italic> is crucial for malaria control in endemic regions. Two targeted-resequencing tools, the Molecular Inversion Probe (MIP) drug resistance panel DR23K and the Multiplexed Amplicons for Drugs, Diagnostics, Diversity, and Differentiation using High-Throughput Targeted Resequencing (MAD<sup>4<\/sup>HatTeR) panel, are widely used to detect resistance genotypes. However, comparisons of their performance for genotyping drug resistance polymorphisms in malaria parasites and their comparative utility for other use cases is lacking.\nMethods:\n To compare the performance of DR23K and MAD<sup>4<\/sup>HatTeR in terms of sequencing depth, sensitivity to minor alleles, and precision, each platform was used to evaluate SNP alleles and microhaplotypes in double- and triple-strain mixtures of well-characterized laboratory parasites at densities of 10, 100, 1,000, and 10,000 parasites\/\u00b5L. In addition, 67 Ugandan field samples collected in 2022 were genotyped using each platform to assess performance and concordance.\nResults:\n Across the four parasite densities, MAD<sup>4<\/sup>HatTeR exhibited superior sequencing depth (mean reads per locus: 144, 992, 1,153, and 1,300) compared to DR23K (mean unique molecular identifiers [UMIs] per locus: 1, 4, 49, and 364). For SNP detection, MAD<sup>4<\/sup>HatTeR achieved 100% sensitivity at 2% within-sample allele frequency (WSAF) at 1,000 and 10,000 parasites\/\u00b5L, whereas DR23K achieved 100% sensitivity at 40% and 5% WSAF at these densities, respectively. Microhaplotype sensitivity was lower for both assays; MAD4HatTeR reached 69% sensitivity at 10 parasites\/\u00b5L when WSAF was \u2265\u200910%, increasing to 100% sensitivity at 2% WSAF and 100 parasites\/\u00b5L. DR23K had\u2009&lt;\u200950% sensitivity at 10 and 100 parasites\/\u00b5L. In field samples, which commonly contain polyclonal infections, high concordance was observed between the two methods for all SNPs (94%, 1,848\/1,969) and polymorphic SNPs (88%, 898\/1,019). All discrepancies were attributed to varied detection of minority alleles in mixed genotype infections.\nConclusions:\n MAD<sup>4<\/sup>HatTeR demonstrated higher sensitivity than DR23K, particularly at low parasite densities. Both assays showed strong concordance for genotyping key resistance mutations in field samples, supporting their reliability. These findings suggest MAD<sup>4<\/sup>HatTeR as the preferred assay for low-density parasite studies and microhaplotype analysis, while DR23K may be appropriate for specific applications with high-parasite density samples, where detection of minority alleles is not prioritized, or when more comprehensive genome coverage is required.<\/p>","DOI":"10.21203\/rs.3.rs-5743980\/v1","type":"posted-content","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T11:03:39Z","timestamp":1737457419000},"source":"Crossref","is-referenced-by-count":0,"title":["Performance of Molecular Inversion Probe DR23K and Paragon MAD4HatTeR Amplicon Sequencing Panels for Detection of Plasmodium falciparum Mutations Associated with Antimalarial Drug Resistance"],"prefix":"10.21203","author":[{"given":"Thomas","family":"Katairo","sequence":"first","affiliation":[{"name":"Infectious Diseases Research Collaboration"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Asua","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bienvenu","family":"Nsengimaana","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Tukwasibwe","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis D","family":"Semakuba","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Innocent","family":"Wiringilimaana","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreeya","family":"Garg","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahiid","family":"Kiyaga","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Mbabazi","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kisakye D","family":"Kabbale","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisen","family":"Ayitewala","sequence":"additional","affiliation":[{"name":"Uganda National Health Laboratory Services (UNHLS)\/Central Public Health Laboratories (CPHL)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel L","family":"Nsobya","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moses R","family":"Kamya","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issac","family":"Ssewanyana","sequence":"additional","affiliation":[{"name":"Infectious Diseases Research Collaboration"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A","family":"Bailey","sequence":"additional","affiliation":[{"name":"Brown University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Aranda-D\u00edaz","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Greenhouse","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Briggs","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa D","family":"Conrad","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"1. World Malaria Report 2024: Addressing Inequity in the Global Malaria Response. \u201d 2024. Geneva: World Health Organization; 2024."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"2. Nsanzabana C, Ariey F, Beck H-P, Ding XC, Kamau E, Krishna S, et al. Molecular assays for antimalarial drug resistance surveillance: A target product profile. PLoS One. 2018;13: e0204347.","DOI":"10.1371\/journal.pone.0204347"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"3. Ruybal-Pes\u00e1ntez S, McCann K, Vibin J, Siegel S, Auburn S, Barry AE. Molecular markers for malaria genetic epidemiology: progress and pitfalls. Trends Parasitol. 2024;40: 147\u2013163.","DOI":"10.1016\/j.pt.2023.11.006"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. Jacob CG, Thuy-Nhien N, Mayxay M, Maude RJ, Quang HH, Hongvanthong B, et al. Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination. Elife. 2021;10. doi:10.7554\/eLife.62997","DOI":"10.7554\/eLife.62997"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"5. Kattenberg JH, Van Dijk NJ, Fern\u00e1ndez-Mi\u00f1ope CA, Guetens P, Mutsaers M, Gamboa D, et al. Molecular surveillance of malaria using the PF AmpliSeq custom assay for Plasmodium falciparum parasites from dried blood spot DNA isolates from Peru. Bio Protoc. 2023;13: e4621.","DOI":"10.21769\/BioProtoc.4621"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Taylor AR, Jacob PE, Neafsey DE, Buckee CO. Estimating relatedness between malaria parasites. Genetics. 2019;212: 1337\u20131351.","DOI":"10.1534\/genetics.119.302120"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"7. Tessema SK, Hathaway NJ, Teyssier NB, Murphy M, Chen A, Aydemir O, et al. Sensitive, highly multiplexed sequencing of microhaplotypes from the Plasmodium falciparum heterozygome. J Infect Dis. 2022;225: 1227\u20131237.","DOI":"10.1093\/infdis\/jiaa527"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. LaVerriere E, Schwabl P, Carrasquilla M, Taylor AR, Johnson ZM, Shieh M, et al. Design and implementation of multiplexed amplicon sequencing panels to serve genomic epidemiology of infectious disease: A malaria case study. Mol Ecol Resour. 2022;22: 2285\u20132303.","DOI":"10.1111\/1755-0998.13622"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"9. de Cesare M, Mwenda M, Jeffreys AE, Chirwa J, Drakeley C, Schneider K, et al. Flexible and cost-effective genomic surveillance ofP. falciparummalaria with targeted nanopore sequencing. bioRxiv. 2023. doi:10.1101\/2023.02.06.527333","DOI":"10.1101\/2023.02.06.527333"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. Holzschuh A, Lerch A, Fakih BS, Aliy SM, Ali MH, Ali MA, et al. Using a mobile nanopore sequencing lab for end-to-end genomic surveillance of Plasmodium falciparum: A feasibility study. PLOS Glob Public Health. 2024;4: e0002743.","DOI":"10.1371\/journal.pgph.0002743"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. Conrad MD, Asua V, Garg S, Giesbrecht D, Niar\u00e9 K, Smith S, et al. Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda. N Engl J Med. 2023;389: 722\u2013732.","DOI":"10.1056\/NEJMoa2211803"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. Aydemir O, Janko M, Hathaway NJ, Verity R, Mwandagalirwa MK, Tshefu AK, et al. Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes. J Infect Dis. 2018;218: 946\u2013955.","DOI":"10.1093\/infdis\/jiy223"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"13. Aranda-D\u00edaz A, Vickers EN, Murie K, Palmer B, Hathaway N, Gerlovina I, et al. Sensitive and modular amplicon sequencing of diversity and resistance for research and public health. bioRxiv. 2024. doi:10.1101\/2024.08.22.609145","DOI":"10.1101\/2024.08.22.609145"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. Mensah BA, Aydemir O, Myers-Hansen JL, Opoku M, Hathaway NJ, Marsh PW, et al. Antimalarial Drug Resistance Profiling of Plasmodium falciparum Infections in Ghana Using Molecular Inversion Probes and Next-Generation Sequencing. Antimicrob Agents Chemother. 2020;64. doi:10.1128\/AAC.01423-19","DOI":"10.1128\/AAC.01423-19"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"15. Hofmann N, Mwingira F, Shekalaghe S, Robinson LJ, Mueller I, Felger I. Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets. PLoS Med. 2015;12: e1001788.","DOI":"10.1371\/journal.pmed.1001788"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"16. Tumwebaze P, Conrad MD, Walakira A, LeClair N, Byaruhanga O, Nakazibwe C, et al. Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children. Antimicrob Agents Chemother. 2015;59: 3018\u20133030.","DOI":"10.1128\/AAC.05141-14"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"17. Aranda-Diaz A, Vickers EN. MAD4HatTeR. 2022 [cited 11 Dec 2024]. Available: https:\/\/www.protocols.io\/view\/mad4hatter-b5gaq3se.pdf","DOI":"10.17504\/protocols.io.14egn779mv5d\/v3"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"18. Tumwebaze PK, Conrad MD, Okitwi M, Orena S, Byaruhanga O, Katairo T, et al. Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda. Nat Commun. 2022;13: 6353.","DOI":"10.1038\/s41467-022-33873-x"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"19. Emiru T, Getachew D, Murphy M, Sedda L, Ejigu LA, Bulto MG, et al. Evidence for a role of Anopheles stephensi in the spread of drug- and diagnosis-resistant malaria in Africa. Nat Med. 2023;29: 3203\u20133211.","DOI":"10.1038\/s41591-023-02641-9"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"20. Boene S, Rovira-Vallbona E, da Silva C, Garc\u00eda-Ulloa M, Rafael B, Canana N, et al. Antimalarial drug resistance and population structure of Plasmodium falciparum in Mozambique using genomic surveillance at health facilities (2021\u20132022). 2024. doi:10.12688\/verixiv.444.1","DOI":"10.12688\/verixiv.444.1"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"21. Chen Y-A, Vickers EN, Aranda-Diaz A, Murphy M, Gerlovina I, Rerolle F, et al. Genomic epidemiology demonstrates spatially clustered, local transmission of Plasmodium falciparum in forest-going populations in southern Lao PDR. PLoS Pathog. 2024;20: e1012194.","DOI":"10.1371\/journal.ppat.1012194"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"22. Chen Y-A, Ng P-Y, Garcia D, Elliot A, Palmer B, Assun\u00e7\u00e3o Carvalho RMC d\u2019, et al. Genetic surveillance reveals low, sustained malaria transmission with clonal replacement in Sao Tome and Principe. medRxiv. 2024. doi:10.1101\/2024.07.15.24309968","DOI":"10.1101\/2024.07.15.24309968"},{"key":"ref23","unstructured":"1. World Malaria Report 2024: Addressing Inequity in the Global Malaria Response. \u201d 2024. Geneva: World Health Organization; 2024."},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"2. Nsanzabana C, Ariey F, Beck H-P, Ding XC, Kamau E, Krishna S, et al. Molecular assays for antimalarial drug resistance surveillance: A target product profile. PLoS One. 2018;13: e0204347.","DOI":"10.1371\/journal.pone.0204347"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"3. Ruybal-Pes\u00e1ntez S, McCann K, Vibin J, Siegel S, Auburn S, Barry AE. Molecular markers for malaria genetic epidemiology: progress and pitfalls. Trends Parasitol. 2024;40: 147\u2013163.","DOI":"10.1016\/j.pt.2023.11.006"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"4. Jacob CG, Thuy-Nhien N, Mayxay M, Maude RJ, Quang HH, Hongvanthong B, et al. Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination. Elife. 2021;10. doi:10.7554\/eLife.62997","DOI":"10.7554\/eLife.62997"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"5. Kattenberg JH, Van Dijk NJ, Fern\u00e1ndez-Mi\u00f1ope CA, Guetens P, Mutsaers M, Gamboa D, et al. Molecular surveillance of malaria using the PF AmpliSeq custom assay for Plasmodium falciparum parasites from dried blood spot DNA isolates from Peru. Bio Protoc. 2023;13: e4621.","DOI":"10.21769\/BioProtoc.4621"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"6. Taylor AR, Jacob PE, Neafsey DE, Buckee CO. Estimating relatedness between malaria parasites. Genetics. 2019;212: 1337\u20131351.","DOI":"10.1534\/genetics.119.302120"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"7. Tessema SK, Hathaway NJ, Teyssier NB, Murphy M, Chen A, Aydemir O, et al. Sensitive, highly multiplexed sequencing of microhaplotypes from the Plasmodium falciparum heterozygome. J Infect Dis. 2022;225: 1227\u20131237.","DOI":"10.1093\/infdis\/jiaa527"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"8. LaVerriere E, Schwabl P, Carrasquilla M, Taylor AR, Johnson ZM, Shieh M, et al. Design and implementation of multiplexed amplicon sequencing panels to serve genomic epidemiology of infectious disease: A malaria case study. Mol Ecol Resour. 2022;22: 2285\u20132303.","DOI":"10.1111\/1755-0998.13622"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"9. de Cesare M, Mwenda M, Jeffreys AE, Chirwa J, Drakeley C, Schneider K, et al. Flexible and cost-effective genomic surveillance ofP. falciparummalaria with targeted nanopore sequencing. bioRxiv. 2023. doi:10.1101\/2023.02.06.527333","DOI":"10.1101\/2023.02.06.527333"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"10. Holzschuh A, Lerch A, Fakih BS, Aliy SM, Ali MH, Ali MA, et al. Using a mobile nanopore sequencing lab for end-to-end genomic surveillance of Plasmodium falciparum: A feasibility study. PLOS Glob Public Health. 2024;4: e0002743.","DOI":"10.1371\/journal.pgph.0002743"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"11. Conrad MD, Asua V, Garg S, Giesbrecht D, Niar\u00e9 K, Smith S, et al. Evolution of Partial Resistance to Artemisinins in Malaria Parasites in Uganda. N Engl J Med. 2023;389: 722\u2013732.","DOI":"10.1056\/NEJMoa2211803"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"12. Aydemir O, Janko M, Hathaway NJ, Verity R, Mwandagalirwa MK, Tshefu AK, et al. Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes. J Infect Dis. 2018;218: 946\u2013955.","DOI":"10.1093\/infdis\/jiy223"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"13. Aranda-D\u00edaz A, Vickers EN, Murie K, Palmer B, Hathaway N, Gerlovina I, et al. Sensitive and modular amplicon sequencing of diversity and resistance for research and public health. bioRxiv. 2024. doi:10.1101\/2024.08.22.609145","DOI":"10.1101\/2024.08.22.609145"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"14. Mensah BA, Aydemir O, Myers-Hansen JL, Opoku M, Hathaway NJ, Marsh PW, et al. Antimalarial Drug Resistance Profiling of Plasmodium falciparum Infections in Ghana Using Molecular Inversion Probes and Next-Generation Sequencing. Antimicrob Agents Chemother. 2020;64. doi:10.1128\/AAC.01423-19","DOI":"10.1128\/AAC.01423-19"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"15. Hofmann N, Mwingira F, Shekalaghe S, Robinson LJ, Mueller I, Felger I. Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets. PLoS Med. 2015;12: e1001788.","DOI":"10.1371\/journal.pmed.1001788"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"16. Tumwebaze P, Conrad MD, Walakira A, LeClair N, Byaruhanga O, Nakazibwe C, et al. Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children. Antimicrob Agents Chemother. 2015;59: 3018\u20133030.","DOI":"10.1128\/AAC.05141-14"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"17. Aranda-Diaz A, Vickers EN. MAD4HatTeR. 2022 [cited 11 Dec 2024]. Available: https:\/\/www.protocols.io\/view\/mad4hatter-b5gaq3se.pdf","DOI":"10.17504\/protocols.io.14egn779mv5d\/v3"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"18. Tumwebaze PK, Conrad MD, Okitwi M, Orena S, Byaruhanga O, Katairo T, et al. Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda. Nat Commun. 2022;13: 6353.","DOI":"10.1038\/s41467-022-33873-x"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"19. Aydemir O, Janko M, Hathaway NJ, Verity R, Mwandagalirwa MK, Tshefu AK, et al. Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes. J Infect Dis. 2018;218: 946\u2013955.","DOI":"10.1093\/infdis\/jiy223"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"20. Emiru T, Getachew D, Murphy M, Sedda L, Ejigu LA, Bulto MG, et al. Evidence for a role of Anopheles stephensi in the spread of drug- and diagnosis-resistant malaria in Africa. Nat Med. 2023;29: 3203\u20133211.","DOI":"10.1038\/s41591-023-02641-9"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"21. Boene S, Rovira-Vallbona E, da Silva C, Garc\u00eda-Ulloa M, Rafael B, Canana N, et al. Antimalarial drug resistance and population structure of Plasmodium falciparum in Mozambique using genomic surveillance at health facilities (2021\u20132022). 2024. doi:10.12688\/verixiv.444.1","DOI":"10.12688\/verixiv.444.1"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"22. Chen Y-A, Vickers EN, Aranda-Diaz A, Murphy M, Gerlovina I, Rerolle F, et al. Genomic epidemiology demonstrates spatially clustered, local transmission of Plasmodium falciparum in forest-going populations in southern Lao PDR. PLoS Pathog. 2024;20: e1012194.","DOI":"10.1371\/journal.ppat.1012194"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"23. Chen Y-A, Ng P-Y, Garcia D, Elliot A, Palmer B, Assun\u00e7\u00e3o Carvalho RMC d\u2019, et al. Genetic surveillance reveals low, sustained malaria transmission with clonal replacement in Sao Tome and Principe. medRxiv. 2024. doi:10.1101\/2024.07.15.24309968","DOI":"10.1101\/2024.07.15.24309968"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5743980\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5743980\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T16:07:28Z","timestamp":1750090048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5743980\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":45,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-5743980\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s12936-025-05441-3","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,1,21]]},"subtype":"preprint"}}